2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8
Canada
514 744 6792
https://www.bauschhealth.com
Setor(es): Healthcare
Indústria: Drug Manufacturers - Specialty & Generic
Funcionários Integrais: 20.270
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Mr. Thomas J. Appio | CEO & Director | 2,74M | N/A | 1962 |
Mr. John S. Barresi | Senior VP, Controller, Chief Accounting Officer & Interim CFO | 796,8k | N/A | 1973 |
Ms. Seana Carson | Executive VP & General Counsel | 872,65k | N/A | 1973 |
Mr. Mirza Dautbegovic | Senior VP & COO | N/A | N/A | N/A |
Mr. Josh Coyle | Senior Vice President of Sales & Salix | N/A | N/A | N/A |
Ms. Kathleen Fitzpatrick | Senior VP & Chief HR Officer | N/A | N/A | N/A |
Dr. Tage Ramakrishna M.D. | Chief Medical Officer and President of R&D | N/A | N/A | 1974 |
Mr. Jeff Hartness | Executive VP of Market Access, Commercial Operations, Neurology, Generics & Government Affairs | N/A | N/A | N/A |
Dr. Graham Jackson | Senior VP & Chief Quality Officer | N/A | N/A | N/A |
Mr. Cees Heiman | Senior Vice President of Europe & Canada | N/A | N/A | N/A |
O QualityScore de governança da ISS da Bausch Health Companies Inc. a partir de 1 de abril de 2024 é 4. As principais pontuações para Auditoria são: 5; Conselho: 2; Direitos de Acionistas: 3; Compensação: 8.